ABSTRACT
ABSTRACT Predator species under field conditions can face different and variable densities of prey species. This work evaluated the functional response of the neotropical lady beetle Eriopis connexa (Coleoptera: Coccinellidae) subjected to different densities of the aphids Brevicoryne brassicae and Aphis craccivora (Hemiptera: Aphididae). Thus, predation rates were analyzed of fourth-instar larvae and one-day old adults of the lady beetle preying upon the aphids at constant densities of 20, 40, 50, 60, and 70 aphids with 15 repetitions per density. The aphids were offered on 5 cm leaf discs of each plant host. The handling times and attack rates were 0.03 h-1 and 0.27 h-1 for larvae and 0.03 h-1 and 0.15 h-1 for adults fed B. brassicae and 0.59 h-1 and 0.35 h-1 for larvae and 0.70 h-1 and 0.95 h-1 for adults fed A. craccivora, respectively. Both larva and adult lady beetles increased predation rate as a function of prey density offered, with an estimated maximum number of prey consumed of 30.3 and 31.6 B. brassicae and 36.3 and 34.6 of A. craccivora by larva and adult lady beetles at the highest prey density, respectively. In conclusion, larvae and adults of E. connexa exhibited a type II functional response.
RESUMEN Las especies de depredadores en condiciones de campo pueden enfrentar densidades diferentes y variables de sus presas. Este trabajo evaluó la respuesta funcional de la mariquita neotropical Eriopis connexa (Coleoptera: Coccinellidae) sometida a diferentes densidades de los pulgones Brevicoryne brassicae y Aphis craccivora (Hemiptera: Aphididae). Se analizaron las tasas de depredación de larvas de cuarto estadio y adultos de un día de vida en las densidades constantes de 20, 40, 50, 60 y 70 pulgones con 15 repeticiones por densidad. Los pulgones se ofrecieron en discos de 5 cm de hojas de la planta huésped. Los tiempos de manejo y las tasas de ataque fueron 0.03 h-1 y 0.27 h-1 para larvas y 0.03 h-1 y 0.15 h-1 para adultos alimentados con B. brassicae y 0.59 h-1 y 0.35 h-1 para larvas y 0.70 h-1 y 0.95 h-1 para adultos alimentados con A. craccivora, respectivamente. Las larvas y las mariquitas adultas aumentaron la tasa de depredación en función de la densidad de presas ofrecidas, con un número máximo estimado de presas consumidas de 30.3 y 31.6 de B. brassicae y 36.3 y 34.6 de A. craccivora para larvas y mariquitas adultas a la mayor densidad de presas, respectivamente. En conclusión, las larvas y los adultos de E. connexa exhibieron una respuesta funcional del tipo II.
Subject(s)
Amphetamine-Related Disorders/therapy , Cocaine-Related Disorders/therapy , Psychotherapy/methods , Adaptation, Psychological , Adult , Aged , Amphetamine-Related Disorders/psychology , Cocaine-Related Disorders/psychology , Cognitive Behavioral Therapy/methods , Counseling/methods , Female , Humans , Male , Middle Aged , Reinforcement, Psychology , Secondary Prevention , Treatment OutcomeABSTRACT
OBJECTIVE: To assess the effectiveness of olanzapine for treating schizophrenia and to assess if olanzapine promotes a better quality of life than first-generation antipsychotics (FGAs). METHOD: Multicenter, naturalistic, randomized controlled study, comparing olanzapine with FGAs, at hospitalization and during a 9-month follow-up. Outcome assessors were blind to the allocated drug. The dose of antipsychotic was determined by doctors according to their clinical practice routines. Data collection was performed from April 1999 to August 2001. RESULTS: 197 patients with DSM-IV-diagnosed schizophrenia were allocated to olanzapine (N = 104) and FGA (N = 93). Patients taking olanzapine showed greater improvements in Positive and Negative Syndrome Scale (PANSS) negative symptoms (mean difference = 2.3, 95% CI = 0.6 to 4.1) and general psychopathology (mean difference = 4.0, 95% CI = 0.8 to 7.2) sub-scales and fewer incidences of tardive dyskinesia (RR = 2.4, 95% CI = 1.4 to 4.2, p < .0001). Olanzapine was also associated with greater improvement in a number of health-related quality-of-life outcomes on the Medical Outcomes Study 36-item Short-Form Health Survey, including physical functioning (mean difference = 6.6, 95% CI = 1.2 to 11.9), physical role limitations (mean difference = 13.7, 95% CI = 3.0 to 24.3), and emotional role limitations (mean difference = 12.1, 95% CI = 0.7 to 23.5). Patients taking olanzapine gained significantly more weight during the trial than patients taking FGAs, with a correspondent endpoint increase in the body mass index (BMI) of 28.7 versus 25.3 (p < .001). CONCLUSION: Compared with FGAs, olanzapine has advantages in terms of improvements of negative symptoms and quality of life. It is also associated with fewer incidences of tardive dyskinesia and greater increases in weight and BMI. These findings are highlighted by the naturalistic approach adopted in this trial.